92 related articles for article (PubMed ID: 1805566)
1. A purified saponin acts as an adjuvant for a T-independent antigen.
White AC; Cloutier P; Coughlin RT
Adv Exp Med Biol; 1991; 303():207-10. PubMed ID: 1805566
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines.
Coughlin RT; Fattom A; Chu C; White AC; Winston S
Vaccine; 1995 Jan; 13(1):17-21. PubMed ID: 7762272
[TBL] [Abstract][Full Text] [Related]
3. Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.
Boyaka PN; Marinaro M; Jackson RJ; van Ginkel FW; Cormet-Boyaka E; Kirk KL; Kensil CR; McGhee JR
J Immunol; 2001 Feb; 166(4):2283-90. PubMed ID: 11160283
[TBL] [Abstract][Full Text] [Related]
4. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen.
So HS; Yoon HS; Choi DY; Kwon YS; Sung JH; Lee TG; Park ES; Cho HS; Lee BM; Cho JM; Ryu WS
Mol Cells; 1997 Apr; 7(2):178-86. PubMed ID: 9163729
[TBL] [Abstract][Full Text] [Related]
5. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
Jirillo E; Kiyono H; Michalek SM; McGhee JR
J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.
van de Wijgert JH; Verheul AF; Snippe H; Check IJ; Hunter RL
Infect Immun; 1991 Aug; 59(8):2750-7. PubMed ID: 1855991
[TBL] [Abstract][Full Text] [Related]
7. Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins.
Palatnik de Sousa CB; Santos WR; Casas CP; Paraguai de Souza E; Tinoco LW; da Silva BP; Palatnik M; Parente JP
Vaccine; 2004 Jun; 22(19):2470-9. PubMed ID: 15193411
[TBL] [Abstract][Full Text] [Related]
8. Saponins as vaccine adjuvants.
Kensil CR
Crit Rev Ther Drug Carrier Syst; 1996; 13(1-2):1-55. PubMed ID: 8853958
[TBL] [Abstract][Full Text] [Related]
9. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
Kensil CR; Patel U; Lennick M; Marciani D
J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
[TBL] [Abstract][Full Text] [Related]
10. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice.
Hiernaux JR; Stashak PW; Cantrell JL; Rudbach JA; Baker PJ
Infect Immun; 1989 May; 57(5):1483-90. PubMed ID: 2707856
[TBL] [Abstract][Full Text] [Related]
12. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
[TBL] [Abstract][Full Text] [Related]
13. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.
Ragupathi G; Gardner JR; Livingston PO; Gin DY
Expert Rev Vaccines; 2011 Apr; 10(4):463-70. PubMed ID: 21506644
[TBL] [Abstract][Full Text] [Related]
14. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
[TBL] [Abstract][Full Text] [Related]
15. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.
Zhou S; Song Y; Nilam A; Luo Y; Huang WC; Long MD; Lovell JF
J Control Release; 2024 May; 369():687-695. PubMed ID: 38575073
[TBL] [Abstract][Full Text] [Related]
16. Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice.
Katayama S; Oda K; Ohgitani T; Hirahara T; Shimizu Y
Vaccine; 1999 Jun; 17(20-21):2733-9. PubMed ID: 10418925
[TBL] [Abstract][Full Text] [Related]
17. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
[TBL] [Abstract][Full Text] [Related]
18. Immunologic responsiveness of the C3H/HeJ mouse: differential ability of butanol-extracted lipopolysaccharide (LPS) to evoke LPS-mediated effects.
Goodman MG; Parks DE; Weigle WO
J Exp Med; 1978 Mar; 147(3):800-13. PubMed ID: 75941
[TBL] [Abstract][Full Text] [Related]
19. QS-21 and QS-7: purified saponin adjuvants.
Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
[TBL] [Abstract][Full Text] [Related]
20. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
